Page last updated: 2024-10-31

midazolam and EHS Tumor

midazolam has been researched along with EHS Tumor in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charles, KA1
Rivory, LP1
Brown, SL1
Liddle, C2
Clarke, SJ2
Robertson, GR1
Sharma, R1
Kacevska, M1
London, R1
Robertson, G1

Other Studies

2 other studies available for midazolam and EHS Tumor

ArticleYear
Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Dec-15, Volume: 12, Issue:24

    Topics: Adjuvants, Anesthesia; Animals; beta-Galactosidase; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme

2006
Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.
    British journal of cancer, 2008, Jan-15, Volume: 98, Issue:1

    Topics: Acute-Phase Proteins; Animals; Anti-Anxiety Agents; ATP Binding Cassette Transporter, Subfamily B; A

2008